rs4796793
Orientation | plus |
Stabilized | plus |
Make rs4796793(C;C) |
Make rs4796793(C;G) |
Make rs4796793(G;G) |
Reference | GRCh38 38.1/141 |
Chromosome | 17 |
Position | 42390192 |
Gene | STAT3 |
is a | snp |
is | mentioned by |
dbSNP | rs4796793 |
dbSNP (classic) | rs4796793 |
ClinGen | rs4796793 |
ebi | rs4796793 |
HLI | rs4796793 |
Exac | rs4796793 |
Gnomad | rs4796793 |
Varsome | rs4796793 |
LitVar | rs4796793 |
Map | rs4796793 |
PheGenI | rs4796793 |
Biobank | rs4796793 |
1000 genomes | rs4796793 |
hgdp | rs4796793 |
ensembl | rs4796793 |
geneview | rs4796793 |
scholar | rs4796793 |
rs4796793 | |
pharmgkb | rs4796793 |
gwascentral | rs4796793 |
openSNP | rs4796793 |
23andMe | rs4796793 |
SNPshot | rs4796793 |
SNPdbe | rs4796793 |
MSV3d | rs4796793 |
GWAS Ctlg | rs4796793 |
GMAF | 0.3411 |
Max Magnitude | 0 |
? | (C;C) (C;G) (G;G) | 28 |
---|---|---|
|
rs4796793, a SNP in the 5' region of the signal transducer and activator 3 STAT3 gene, has been linked in a study of 75 Japanese patients to (successful) response to interferon-alpha immunotherapy for metastatic kidney cancer. [PMID 17602083]
From this paper [PMID 17602083]:
"... rs4796793 was the most significant predictor of IFN-alpha response (odds ratio [OR] = 2.73; 95% CI, 1.38 to 5.78). The highest OR was shown in the (C;C) genotype ... compared to the (G;G) + (G;C) genotypes (OR = 8.38, 95% CI, 1.63 to 42.96)."
[PMID 19604093] Genetic polymorphisms, their allele combinations and IFN-beta treatment response in Irish multiple sclerosis patients.
[PMID 21948258] Association between polymorphisms in the signal transducer and activator of transcription and dilated cardiomyopathy in the Chinese Han population.
[PMID 24781989] Association between STAT3 gene polymorphisms and ulcerative colitis susceptibility: a case-control study in the Chinese Han population
[PMID 25973100] STAT3 and STAT5b polymorphism contributes to breast cancer risk and clinical outcomes